Colloquium Meetings 2025-2026
David Nutt
20 Years of Psychedelic Research – and 21 Learnings
20th March 2026
David Nutt is a psychiatrist and the Edmond J. Safra Professor of Neuropsychopharmacology in Imperial College London and Chief Research Officer of Awaknlifesciences. He is currently Founding Chair of the charity DrugScience.org.uk and has been president of the European Brain Council, the BAP, BNA, and ECNP. David has published 35 books and over 1000 research papers that define his many landmark contributions to psychopharmacology including GABA and noradrenaline receptor function in anxiety disorders, serotonin function in depression, endorphin and dopamine function in addiction and the neuroscience and clinical utility of psychedelics.
Abstract:
Its 20 years since I began to research psychedelics at Bristol University with Robin Carhart-Harris with our conducting the first fMRI studies of psilocybin. The field has massively expanded since then into more drugs, more measures and much more clinical work. My talk will cover what are the 20 most important learnings for me in that period.